NCT04636723View on ClinicalTrials.gov

Neuroinflammation in Chronic Systemic Symptoms (CSS)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions
CancerCancer Head NeckNeuroinflammatory ResponseChronic InflammationChronic DiseaseChronic Pain
Trial Locations (1)

37203

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
collaborator

Vanderbilt-Ingram Cancer Center

OTHER

lead

Vanderbilt University Medical Center

OTHER

NCT04636723 - Neuroinflammation in Chronic Systemic Symptoms (CSS) | Biotech Hunter | Biotech Hunter